NASDAQ:INOV

Inovalon Stock Forecast, Price & News

$26.38

-0.36 (-1.35 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$25.73

Now: $26.38▼

$26.86

50-Day Range

$18.01

MA: $19.49▼

$26.74

52-Week Range

$13.39

Now: $26.38▼

$27.93

Volume808,846 shs

Average Volume660,834 shs

Market Capitalization$4.10 billion

P/E Ratio659.66

Dividend YieldN/A

Beta0.64

Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

MarketRank^™

Overall MarketRank^™

1.41 out of 5 stars

Computer And Technology Sector

349th out of 1,259 stocks

Data Processing & Preparation Industry

25th out of 79 stocks

1.2 Analyst's Opinion

Consensus Rating
Inovalon has received a consensus rating of Hold. The company's average rating score is 2.44, and is based on 5 buy ratings, 3 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $24.11, Inovalon has a forecasted downside of 8.6% from its current price of $26.38.
Amount of Analyst Coverage
Inovalon has only been the subject of 3 research reports in the past 90 days.

2.3 Community Rank

Outperform Votes
Inovalon has received 336 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Inovalon has received 386 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Inovalon has received 53.46% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote “Outperform” if you believe INOV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Inovalon does not currently pay a dividend.
Dividend Growth
Inovalon does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inovalon insiders have bought 447.27% more of their company's stock than they have sold. Specifically, they have bought $1,657,450.00 in company stock and sold $302,859.00 in company stock.
Percentage Held by Insiders
49.59% of the stock of Inovalon is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 33.64% of the stock of Inovalon is held by institutions.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Inovalon are expected to grow by 31.11% in the coming year, from $0.45 to $0.59 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Inovalon is 659.66, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.51.
Price to Earnings Ratio vs. Sector
The P/E ratio of Inovalon is 659.66, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 91.63.
Price to Earnings Growth Ratio
Inovalon has a PEG Ratio of 2.19. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Inovalon has a P/B Ratio of 5.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Data processing & preparation

Sub-IndustryN/A

SectorComputer and Technology

Current SymbolNASDAQ:INOV

Previous Symbol

CUSIPN/A

CIK1619954

Webwww.inovalon.com

Phone301-809-4000

Employees2,662

Debt

Debt-to-Equity Ratio1.33

Current Ratio1.95

Quick Ratio1.95

Price-To-Earnings

Trailing P/E Ratio659.66

Forward P/E Ratio58.62

P/E Growth2.19

Sales & Book Value

Annual Sales$642.41 million

Price / Sales6.38

Cash Flow$1.12 per share

Price / Cash Flow23.46

Book Value$4.44 per share

Price / Book5.94

Profitability

EPS (Most Recent Fiscal Year)$0.41

Net Income$7.78 million

Net Margins0.87%

Return on Equity9.07%

Return on Assets3.18%

Miscellaneous

Outstanding Shares155,400,000

Market Cap$4.10 billion

Next Earnings Date2/3/2021 (Confirmed)

OptionableOptionable

$26.38

-0.36 (-1.35 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Inovalon (NASDAQ:INOV) Frequently Asked Questions

How has Inovalon's stock been impacted by Coronavirus (COVID-19)?

Inovalon's stock was trading at $17.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INOV shares have increased by 52.0% and is now trading at $26.38.
View which stocks have been most impacted by COVID-19.

Is Inovalon a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Inovalon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INOV, but not buy additional shares or sell existing shares.
View analyst ratings for Inovalon or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Inovalon?

Wall Street analysts have given Inovalon a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Inovalon wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Inovalon's next earnings date?

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Inovalon.

How can I listen to Inovalon's earnings call?

Inovalon will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Inovalon's earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) issued its earnings results on Wednesday, October, 28th. The technology company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.04. The technology company earned $161.38 million during the quarter, compared to analyst estimates of $179.27 million. Inovalon had a return on equity of 9.07% and a net margin of 0.87%.
View Inovalon's earnings history.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon issued an update on its FY21 earnings guidance on Monday, January, 11th. The company provided EPS guidance of $0.73-0.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.63. The company issued revenue guidance of $741-768 million, compared to the consensus revenue estimate of $749.45 million.

What price target have analysts set for INOV?

9 equities research analysts have issued 12 month target prices for Inovalon's stock. Their forecasts range from $15.00 to $30.00. On average, they expect Inovalon's share price to reach $24.11 in the next year. This suggests that the stock has a possible downside of 8.6%.
View analysts' price targets for Inovalon or view Wall Street analyst' top-rated stocks.

Who are some of Inovalon's key competitors?

Some companies that are related to Inovalon include Autohome (ATHM), Five9 (FIVN), Pegasystems (PEGA), Zynga (ZNGA), Globant (GLOB), Proofpoint (PFPT), Change Healthcare (CHNG), JOYY (YY), DXC Technology (DXC), CoreLogic (CLGX), LiveRamp (RAMP), Upwork (UPWK), Perspecta (PRSP), 8X8 (EGHT) and CarGurus (CARG).
View all of INOV's competitors.

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

Who are Inovalon's key executives?

Inovalon's management team includes the following people:

Dr. Keith R. Dunleavy, Founder, Chairman & CEO (Age 51, Pay $210.55k)
Mr. Robert A. Wychulis, Pres (Age 65, Pay $858.81k)
Mr. Jonathan R. Boldt CPA, Chief Financial Officer (Age 35, Pay $677.07k)
Mr. Peter De Bock, Chief Admin. Officer (Age 57, Pay $766.72k)
Mr. Jason B. Capitel, Chief Commercial Officer (Age 48, Pay $1.45M)
Mr. Geoff Charron, Chief Technology Officer
Hulus Alpay, VP of Investor Relations
Ms. Beverly Allen, Gen. Counsel, Chief Compliance & Privacy Officer
Kim E. Collins, Sr. VP of Corp. Marketing & Communications
Ms. Ingrid E. Olsen, Chief People Officer

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Who are Inovalon's major shareholders?

Inovalon's stock is owned by many different retail and institutional investors. Top institutional investors include Spence Asset Management (0.24%). Company insiders that own Inovalon stock include Bock Peter De, Jason Capitel, Jonathan R Boldt, Keith R Dunleavy, Robert A Wychulis and William J Teuber Jr.
View institutional ownership trends for Inovalon.

Which major investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Spence Asset Management. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Robert A Wychulis.
View insider buying and selling activity for Inovalon or view top insider-selling stocks.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $26.38.

How big of a company is Inovalon?

Inovalon has a market capitalization of $4.10 billion and generates $642.41 million in revenue each year. The technology company earns $7.78 million in net income (profit) each year or $0.41 on an earnings per share basis. Inovalon employs 2,662 workers across the globe.

What is Inovalon's official website?

The official website for Inovalon is www.inovalon.com.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here